Cargando…

Fludarabine Inhibits K(V)1.3 Currents in Human B Lymphocytes

Fludarabine (F-ara-A) is a purine analog commonly used in the treatment of indolent B cell malignancies that interferes with different aspects of DNA and RNA synthesis. K(V)1.3 K(+) channels are membrane proteins involved in the maintenance of K(+) homeostasis and the resting potential of the cell,...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Cruz, Alicia, Vera-Zambrano, Alba, Peraza, Diego A., Valenzuela, Carmen, Zapata, Juan M., Perez-Chacon, Gema, Gonzalez, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374215/ https://www.ncbi.nlm.nih.gov/pubmed/28408885 http://dx.doi.org/10.3389/fphar.2017.00177

Ejemplares similares

K(V)1.5–K(V)β1.3 Recycling Is PKC-Dependent
por: Macias, Alvaro, et al.
Publicado: (2021)

Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model
por: Rebolleda, Nerea, et al.
Publicado: (2016)

T-cell large granular lymphocytic leukemia: treatment experience with fludarabine
por: Costa, Renata Oliveira, et al.
Publicado: (2012)

Fludarabine in the treatment of chronic lymphocytic leukemia: a review
por: Ricci, Francesca, et al.
Publicado: (2009)

Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
por: Janssens, Ann, et al.
Publicado: (2009)

Polyunsaturated Fatty Acids Modify the Gating of Kv Channels
por: Moreno, Cristina, et al.
Publicado: (2012)

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010)

Telomerase Contributes to Fludarabine Resistance in Primary Human Leukemic Lymphocytes
por: Shawi, May, et al.
Publicado: (2013)

The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart
por: Perez-Chacon, Gema, et al.
Publicado: (2021)

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
por: Gassner, Franz Josef, et al.
Publicado: (2010)

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
por: Montillo, Marco, et al.
Publicado: (2008)

Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia
por: Soyaltin, Utku Erdem, et al.
Publicado: (2016)

Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
por: Moussay, Etienne, et al.
Publicado: (2010)

Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia
por: Ooi, Melissa G, et al.
Publicado: (2009)

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine
por: Mandrik, Olena, et al.
Publicado: (2015)

Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide
por: Amigo-Jiménez, Irene, et al.
Publicado: (2014)

Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
por: Huang, Chunfa, et al.
Publicado: (2018)

Tuning Scorpion Toxin Selectivity: Switching From K(V)1.1 to K(V)1.3
por: Gigolaev, Andrei M., et al.
Publicado: (2020)

Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
por: Markakis, Ioannis, et al.
Publicado: (2021)

Neurological illness following treatment with fludarabine.
por: Johnson, P. W., et al.
Publicado: (1994)

[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019)

Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2022)

EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
por: Valsecchi, Roberta, et al.
Publicado: (2020)

A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
por: Izutsu, Koji, et al.
Publicado: (2020)

In-Depth Study of the Interaction, Sensitivity, and Gating Modulation by PUFAs on K(+) Channels; Interaction and New Targets
por: Moreno, Cristina, et al.
Publicado: (2016)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia
por: Garrote, Heidys, et al.
Publicado: (2015)

Physiological implications of NTBI uptake by T lymphocytes
por: Pinto, Jorge P., et al.
Publicado: (2014)

Immune Checkpoint Inhibitors Regulate K(+) Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients
por: Gawali, Vaibhavkumar S., et al.
Publicado: (2021)

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2023)

Inhibition of Small-Conductance, Ca(2+)-Activated K(+) Current by Ondansetron
por: Guo, Shuai, et al.
Publicado: (2021)

Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
por: Arampatzis, Spyridon, et al.
Publicado: (2011)

Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients
por: Russo, M, et al.
Publicado: (2010)

Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Hwang, William Y. K., et al.
Publicado: (2009)

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia
por: Palermo, G, et al.
Publicado: (2015)

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia
por: Gauthier, Martin, et al.
Publicado: (2019)

γδ T Lymphocytes Coordinate Eosinophil Influx during Allergic Responses
por: de Oliveira Henriques, Maria Das Graças Muller, et al.
Publicado: (2012)

The Effect of Pungent and Tingling Compounds from Piper nigrum L. on Background K(+) Currents
por: Beltrán, Leopoldo R., et al.
Publicado: (2017)

High Effectiveness in Actions of Carfilzomib on Delayed-Rectifier K(+) Current and on Spontaneous Action Potentials
por: So, Edmund Cheung, et al.
Publicado: (2019)

DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status
por: Grgurevic, Srdana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4cvutc88pevsvu5i4ljh6mvj3v